Candel Therapeutics (CADL)

• Market cap: $374M
• 1 day: -0.2%
• 5 days: 4.08%
• 1 month: -7.78%
• 3 months: -21.17%
• 6 months: 3.66%
• Year to date: -6.25%
• 1 year: -36.33%
• 5 years: -27.14%
• 10 years: -27.14%
• Sector: Healthcare
• Industry: Biotechnology

About: Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Employees: 38